E.VITALGROUP

PELVIDOL 20 TABLETS

PELVIDOL 20 TABLETS

1 1
  • Secure payment
  • Discreet and sanitized package
  • Fast and safe shipping

Description

Descriptive sheet

Pelvidol

Description
Dietary supplement based on Alpha Lipoic Acid and Magnesium. It can be used in cases of oxidative stress, primary dysmenorrhea, premenstrual syndrome, to maintain uterine quiescence throughout pregnancy, and in all cases of increased risk of uterine contractions (e.g., invasive prenatal diagnostic procedures: chorionic villus sampling, amniocentesis, cordocentesis).

Nutritional characteristics
per 1 tablet
Alpha Lipoic Acid 600 mg
Magnesium 241.2 mg

Warnings
Do not exceed the recommended daily dose. Keep out of reach of children under 3 years of age. Supplements should not be used as a substitute for a varied diet.

Conservation
Store at room temperature.
Shelf life in unopened packaging: 24 months.

Format
Pack of 20 tablets.

E.VITALGROUP

PELVIDOL 20 TABLETS

PELVIDOL 20 TABLETS

MINSAN code: 925490880
Previous price: €23,22
€23,22
€23,50 €23,22
-1% Sold out
Tax included. Shipping calculated at checkout.
View full details

Product images are purely indicative and may not be fully representative of the packaging and product features, as they may vary in color, size, or content. Any decorations, gift wrapping, and items included in the images for product presentation purposes will not be shipped with orders. Product names, ingredients, and percentages indicated in the descriptions are purely indicative and may be subject to change or updates by the manufacturers. Due to the impossibility of updating these updates in real time, the photos and technical information of the products listed on farmaInnovation.it may differ from those shown on the label or otherwise disclosed by the manufacturers. The only identifying element is the MINSAN (Ministry of Health) code. Farmacia Barni, farmainnovation.it , does not guarantee the accuracy and timeliness of the information published and declines all responsibility for any errors, omissions, or failure to update it. farmainnovation.it assumes no responsibility for damages of any kind that may arise from accessing the published information.